London School of Hygiene and Tropical Medicine

London School of Hygiene and Tropical Medicine logo
🇧🇪Belgium
Ownership
Private
Established
1899-01-01
Employees
1K
Market Cap
-
Website
http://www.lshtm.ac.uk
news-medical.net
·

COP29 outcomes fall short on climate health action

COP29 agreements fell short in addressing climate change impacts on health, with $300 billion pledged annually to poorer countries by 2035, far below the $1.3 trillion sought. LSHTM experts emphasized the need for a just transition to net zero and proper financing, highlighting the health benefits of climate action. Despite some progress, discussions on mitigation were postponed, and the health community fears millions will remain unprotected.
pharmabiz.com
·

Studies of Ayush-ICMR centres will produce national dossiers for global

Union Ayush Ministry collaborates with ICMR to scientifically validate Ayush therapies, establishing Ayush-ICMR centers at AIIMS campuses for mechanistic studies. Focus areas include gastrointestinal health, women and child health, cancer care, and geriatric health. An MoU with DBT facilitates biotechnological research on Ayush interventions, and the ABIHR programme integrates Ayurveda with modern sciences. The Ministry also partners with international institutions to study Ayush interventions for long Covid and other conditions, aiming to globally validate Ayush practices.
miragenews.com
·

Cancer Patients Prefer Proven Success Over Fast Drug OKs

US survey shows cancer patients may prefer to wait up to 22 additional months for FDA approval of new cancer drugs to ensure their effectiveness, highlighting the importance of robust evaluation over expediency.
drugs.com
·

Heat Stress in Pregnancy Might Affect a Babies' Development Later

Heat stress during pregnancy can impact infant development, leading to low birth weight and stunted growth. Infants exposed to higher temperatures in the first trimester and at age 1 were more likely to weigh less for their height and age. Researchers suggest exploring populations most affected to develop public health measures.
bmj.com
·

Non-communicable diseases: research priorities to mitigate impact of health system shocks

Non-communicable diseases were neglected during the COVID-19 pandemic despite causing higher mortality. Research and policy must integrate these diseases into future health shock responses, addressing culture, evidence, resources, and data to ensure comprehensive preparedness.
contagionlive.com
·

Fractional Doses of Pneumococcal Vaccine Could Bolster Supply in Under-Resourced Regions

A 40% fractional dose of PCV13 was noninferior to a full dose in immunizing infants, suggesting cost-saving potential for vaccination programs in low- and middle-income countries. The study highlights the high cost of pneumococcal vaccines and the need for price reductions to sustain immunization efforts.

Trial Emulation Study Taps Real-World Data to Help Fill Evidence Gaps

UK researchers emulated an RCT comparing blood thinners using real-world data, finding similar treatment effects but noting differences in patient demographics and medication use. This approach aims to fill evidence gaps for underrepresented groups in RCTs.
wired-gov.net
·

UKRI and Government of India address global challenges

UKRI India and the Government of India have jointly funded £19.4 million for research in farmed animal diseases, understanding geohazards, and sustainable materials. The collaboration includes projects led by UK and Indian researchers, focusing on improving farmed animal health, understanding geohazards, and developing sustainable industrial practices.

Researchers attempted to emulate a clinical trial using data from real patients

Researchers emulated a randomized controlled trial using UK health data to compare apixaban and warfarin for stroke prevention in atrial fibrillation patients, finding similar outcomes but no superiority of apixaban, suggesting differences in warfarin control, apixaban dosing, and patient demographics may affect results.
medicalxpress.com
·

Researchers attempt to emulate a clinical trial using data from real patients

Researchers used UK real-world clinical data to emulate a trial comparing apixaban and warfarin for stroke prevention in atrial fibrillation patients, finding similar outcomes but no superiority of apixaban, suggesting the method's effectiveness for underrepresented patient groups.
© Copyright 2024. All Rights Reserved by MedPath